About Us
Our Partnership
Key Structures
Engage With Us
Topics
Replenishment
Our Financing
Impact Stories
-
09 May 2023Meet Health Workers Fighting HIV, TB and Malaria in Viet Nam
-
17 April 2023For Fazila and Millions of Others in Pakistan, Climate Change Brings Extreme Floods and Malaria
-
23 March 2023“But I Can’t Just Give Up.” In the Shadow of War, Yulia Continues to Support People with TB in Ukraine
-
21 March 2023Tools to Turbocharge the Fight Against Tuberculosis
Media Resources
News Releases
Opinion
Publication Categories
Resources
GF/B37/DP12
Approved by the Board on: 04 May 2017
Amended and Restated Global Fund Quality Assurance Policy for Diagnostic Products
Based on the recommendation of the Strategy Committee, the Board approves the amended and restated Global Fund Quality Assurance Policy for Diagnostic Products, as set forth in Annex 1 to GF/B37/06.
The Global Fund uses cookies for anonymized statistics on website use and content performance to help us improve and adapt the website. To consent to the use of cookies, please click “Accept”. To learn more about your rights and options, please read our Privacy Statement.